HOME › DRUGS › NELARABINE
ACTIVE SUBSTANCE / INN

NELARABINE

Brand name(s): ARRANON, NELARABINE, Atriance
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
NDA021877
ACTIVE SUBSTANCE
Nelarabine
REGULATORS
FDA · EMA
SPONSORS / MAH
SANDOZ, Sandoz Pharmaceuticals d.d., XGEN PHARMS
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
NELARABINEANDA216510XGEN PHARMSPrescription
ARRANONNDA021877SANDOZPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AtrianceSandoz Pharmaceuticals d.d.Authorised22/08/2007Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

FULL INTELLIGENCE ON NELARABINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →